Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Market Cap	1.20T +265.9%
Revenue (ttm)	575.66B -5.7%
Net Income	27.92B
EPS	980.93
Shares Out	31.51M
PE Ratio	38.79
Forward PE	27.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	507,777
Average Volume	966,749
Open	38,750
Previous Close	39,300
Day's Range	37,600 - 38,750
52-Week Range	10,300 - 45,050
Beta	1.14
RSI	50.30
Earnings Date	Feb 6, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 1,061
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 249420

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.